Tonix Pharmaceuticals Holding Corp. (TNXP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 132.95M |
| Enterprise Value | -73.38M |
| P/E Ratio | -0.39 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 3.06 |
| Price/Book Ratio | 0.39 |
| Enterprise/Revenue | -2.95 |
| Enterprise/EBITDA | 0.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -5.49 |
| Operating Margin | -5.68 |
AD
Management Effectiveness
| Return On Assets | -0.63 |
| Return On Equity | -0.69 |
Income Statement
| Revenue | 13.11M |
| Revenue/Share | 1.75 |
| Gross Profit | 4.54M |
| EBITDA | -122.01M |
| Net Income | -124.02M |
| Diluted EPS | -14.57 |
Balance Sheet
| Total Cash | 176.23M |
| Total Cash/Share | 10.59 |
| Total Debt | 1.27M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 6.61 |
| Book Value Per Share | 13.36 |
Price History
| 52-Week Change | -72.48 |
| 52-Week High | 20.58 |
| 52-Week Low | 5.2 |
| Moving Average 50 Days | 10.55 |
| Moving Average 200 Days | 12.84 |
Statistics
| Average Volume | 628,054 |
| Shares Outstanding | 17.15M |
| % Held by Institutions | 68.7 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
| Last Split Date | February 05, 2025 |
AD
